Abstract
Purpose: To report the occurrence of posterior ocular adverse events following the administration of the BNT162b2 mRNA vaccine against SARS-CoV-2. Methods: A retrospective consecutive case series, in which the medical files of patients presenting with ocular adverse events within 30 days of the vaccine inoculation, were analyzed. Results: Four patients (2 females) were included in the study. The diagnoses included: posterior scleritis, paracentral acute middle maculopathy, herpes panuveitis, and Vogt–Koyanagi–Harada (VKH)-like uveitis. Three of the patients had no relevant ocular history, but the patient who developed scleritis was in remission without medical therapy for four years, until the flare-up, which occurred one day after the vaccine. All patients improved with treatment. Conclusion: Though a causal relationship cannot be definitively established, the temporal relationship suggests a possible link between the COVID-19 vaccine and the posterior ocular complications. The benefits of vaccination clearly outweigh the potential adverse effects; however, ophthalmologists should be aware of the potential for vaccine-associated uveitis.
| Original language | English |
|---|---|
| Pages (from-to) | 1677-1686 |
| Number of pages | 10 |
| Journal | International Ophthalmology |
| Volume | 43 |
| Issue number | 5 |
| DOIs | |
| State | Published - May 2023 |
Bibliographical note
Publisher Copyright:© 2022, The Author(s), under exclusive licence to Springer Nature B.V.
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- COVID-19
- Herpes
- Ocular inflammation
- PAMM
- SARS-CoV-2
- Scleritis
- Uveitis
- Vaccine
Fingerprint
Dive into the research topics of 'Posterior ocular manifestations following BNT162b2 mRNA COVID-19 vaccine: a case series'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver